DCSIMG
For you to enjoy all the features of this website Bedford Today requires permission to use cookies.
Find Out More
  • What is a Cookie?

  • What is a Flash Cookie?

  • Can I opt out of receiving Cookies?

  • About our Cookies

  • Cookies are small data files which are sent to your browser (Internet Explorer, Firefox, Chrome etc) from a website you visit. They are stored on your electronic device.

  • This is a type of cookie which is collected by Adobe Flash media player (it is also called a Local Shared Object) - a piece of software you may already have on your electronic device to help you watch online videos and listen to podcasts.

  • Yes there are a number of options available, you can set your browser either to reject all cookies, to allow only "trusted" sites to set them, or to only accept them from the site you are currently on.

    However, please note - if you block/delete all cookies, some features of our websites, such as remembering your login details, or the site branding for your local newspaper may not function as a result.

  • The types of cookies we, our ad network and technology partners use are listed below:

    • Revenue Science

      A tool used by some of our advertisers to target adverts to you based on pages you have visited in the past. To opt out of this type of targeting you can visit the 'Your Online Choices' website by clicking here.

    • Google Ads

      Our sites contain advertising from Google; these use cookies to ensure you get adverts relevant to you. You can tailor the type of ads you receive by visiting here or to opt out of this type of targeting you can visit the 'Your Online Choices' website by clicking here.

    • Webtrends / Google Analytics

      This is used to help us identify unique visitors to our websites. This data is anonymous and we cannot use this to uniquely identify individuals and their usage of the sites.

    • Dart for Publishers

      This comes from our ad serving technology and is used to track how many times you have seen a particular ad on our sites, so that you don't just see one advert but an even spread. This information is not used by us for any other type of audience recording or monitoring.

    • ComScore

      ComScore monitor and externally verify our site traffic data for use within the advertising industry. Any data collected is anonymous statistical data and cannot be traced back to an individual.

    • Local Targeting

      Our Classified websites (Photos, Motors, Jobs and Property Today) use cookies to ensure you get the correct local newspaper branding and content when you visit them. These cookies store no personally identifiable information.

    • Grapeshot

      We use Grapeshot as a contextual targeting technology, allowing us to create custom groups of stories outside out of our usual site navigation. Grapeshot stores the categories of story you have been exposed to. Their privacy policy and opt out option can be accessed here.

    • Subscriptions Online

      Our partner for Newspaper subscriptions online stores data from the forms you complete in these to increase the usability of the site and enhance user experience.

    • Add This

      Add This provides the social networking widget found in many of our pages. This widget gives you the tools to bookmark our websites, blog, share, tweet and email our content to a friend.

    • 3rd Party Cookies

      We use Advertising agencies to provide us with some of the advertising on our websites. These include (but are not limited to) Specific Media, The Rubicon Project, AdJug, AdConion, Context Web. Please click on the provider name to visit their opt-out page.

Sponsored by Michael R Peters
Gut defence mechanism discovered

“The way cells in gut fight off toxins produced by a hospital bug has been discovered,” BBC News has reported.

In new research, scientists have shown that infection with the bacteria Clostridium difficile stimulates cells in the gut to modify the toxins produced by the bacteria. This modification, called nitrosylation, protects the body by making the toxins inactive. Researchers then found that a chemical called GSNO that encourages nitrosylation could be used to treat mice infected with Clostridium difficile, the bacteria behind a high proportion of hospital-acquired infectious diarrhoea and life-threatening colon inflammation.

This study’s exploration of nitrosylation has contributed to our understanding of how host organisms can protect themselves against toxins produced by organisms such as C. difficile. The researchers add that a larger number of microbial enzymes are similar to the C. difficile toxins, and that nitrosylation may represent a common form of defence mechanism against microbes. However, many of the body’s naturally-occurring proteins can also be nitrosylated, not just toxins from bacteria. Therefore, as the researchers conclude, before these finding can be used to develop a treatment against bacterial infections, scientists must find a way to target only those substances that are harmful to the body.

 

Where did the story come from?

The study was carried out by researchers from the University of Texas and a number of other American research institutes. It was funded by several organisations, including the Howard Hughes Medical Institute and various arms of the US National Institutes of Health. The study was published in the peer-reviewed journal, Nature Medicine.

The BBC reported the findings of this study well.

 

What kind of research was this?

This was animal and laboratory-based research, which used mouse model and cell culture-based techniques to examine cells’ response to infection with the bacteria Clostridium difficile. Infection with C. difficile is reported to be the most common cause of hospital-acquired infectious diarrhoea and life-threatening inflammation of the colon (colitis) worldwide.

The strains of C. difficile that cause disease produce several toxins, including two called TcdA and TcdB. These toxins inactivate enzymes in the infected person or animal (known as ‘the host’) and cause diarrhoea and inflammation once they have entered host cells. However, to become toxic, the toxin molecules have to ‘cleave’ or split themselves into smaller parts so that they can enter the cells of the gut. This paper identified a mechanism that operates in host organisms to reduce the cleavage of the toxins, and explored the potential of exploiting this mechanism to treat mice with C. difficile infections.

 

What did the research involve?

In this study the researchers performed a range of experiments to look at a range of biological and chemical mechanisms behind the body’s defences against the bacteria C. difficile.

The researchers started by creating an animal “model” of C. difficile infection that they could study. To do this they injected purified TcdA toxin into the small intestines of mice. Previous work has suggested that the body limits the toxic effects of C. difficile by using a process called nitrosylation, which chemically modifies proteins.

To further explore the role of nitrosylation the researchers looked at the levels of a chemical called S-nitrosogluthathione (GSNO), which is often required for nitrosylation to take place. To do so, they compared levels of GSNO areas of the gut of mice that had been injected with the toxin and in areas left uninfected. They also looked at the levels of modified (nitrosylated) proteins in infected and uninfected gut tissues. The researchers also identified which specific proteins had been nitrosylated.

The researchers then examined the levels of modified (nitrosylated) proteins in tissue samples from human colon tissue that was actively affected by inflammation. The researchers used their observations to construct a cell-based model to examine the potential role that toxin nitrosylation might play in protecting host cells from toxins. To confirm their findings, they injected nitrosylated TcdA toxin into mice to see whether it had the same effect as un-nitrosylated TcdA.

The researchers then examined and modelled the protein structure of the toxins TcdA and TcdB to identify the exact location on the protein molecule that nitrosylation modifies to bring about reduced toxicity. They then confirmed the sites of modification using a variety of experimental techniques.

Finally, the researchers used their findings to investigate whether GSNO (a chemical that causes nitrosylation) could be used to protect mice against C. difficile toxicity. They tested the effects of GSNO first on cells in the laboratory, and then on mice. To do this they injected the small intestines of mice with Tcd toxins, then injected some of the mice with GSNO as well. They then looked at whether the Tcd toxins had less effect in the mice injected with GSNO. They also tested the effects of GSNO given by mouth in another mouse model that closely resembles human C. difficile infection.

 

What were the basic results?

TcdA injection into the small intestine of mice caused damage to the lining of the intestine (called the intestinal mucosa). It could also cause fluid secretion into the intestine (which is what leads to diarrhoea) and the accumulation of white blood cells and other signs of inflammation.

There was a 12.1-fold increase in tissue levels of the chemical GSNO in tissues of animals injected with TcdA compared to animals injected with a “dummy” solution that lacked the toxin. There were also high levels of modified (nitrosylated) proteins in TcdA-exposed tissues, both in mice and humans. The researchers found that TcdA was itself a target for this modification.

The cell-based model showed that nitrosylation of the TcdA toxin protected the cells against the toxin’s effects. When nitrosylated TcdA was injected into mice it was less toxic than unmodified TcdA. The related toxin TcdB was also found to be nitrosylated. The researchers found that the nitrosylation occurred at the catalytic site that allows the toxins to be cleaved (a process which is necessary for toxicity), preventing it from occurring.

GSNO protected against Tcd toxicity in cells grown in the laboratory. Injection of GSNO into the intestine of mice reduced TcdA-induced symptoms, including inflammation and fluid secretion. Administering oral GSNO also increased survival in another mouse model of human C. difficile infection.

 

How did the researchers interpret the results?

The authors concluded that host organisms exhibit nitrosylation of C. difficile toxins, which reduces their harmful effects by preventing the toxin molecules from splitting and entering cells. They say that promotion of the nitrosylation process can be used to treat C. difficile infection in mice, and that this finding may suggest new treatment approaches for humans.

 

Conclusion

This study has contributed to our understanding of how host organisms defend themselves against toxins produced by C. difficile. It found that both mice and humans modify the toxins using a process called nitrosylation, and this decreases their toxicity. The researchers add that a large number of microbial proteins are similar to the C. difficile toxins, and that nitrosylation may be a common defence mechanism against microorganisms.

The study also found that the chemical GSNO, which is often required for nitrosylation, was effective in treating C. difficile infection in mice. However, it is not just these bacterial proteins that can nitrosylated - many other important proteins in the body can also undergo the process. Therefore, as the researchers conclude, the ability to selectively target the toxins or other proteins involved in disease (but not other proteins) remains a major challenge. This will have to be addressed before treatments based on this finding could be further investigated for C. difficile.


loading...
Find It

"Business owner? - Claim your business and Advertise with us"

In association with qype logo

Looking for...

Featured advertisers

Jobs

Search for a job

Motors

Search for a car

Property

Search for a house

Weather for Bedford

Monday 28 May 2012

5 day forecast

Today

Sunny

Sunny

Temperature: 11 C to 25 C

Wind Speed: 13 mph

Wind direction: East

Tomorrow

Cloudy

Cloudy

Temperature: 12 C to 19 C

Wind Speed: 9 mph

Wind direction: North east

Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.

Bedford Today provides news, events and sport features from the Bedford area. For the best up to date information relating to Bedford and the surrounding areas visit us at Bedford Today regularly or bookmark this page.